ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q4 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $186,532 | -81.9% | 2,090 | -76.1% | 0.03% | -77.8% |
| Q1 2022 | $1,028,000 | -9.0% | 8,763 | +4.3% | 0.14% | -19.6% |
| Q4 2021 | $1,130,000 | -15.6% | 8,400 | 0.0% | 0.17% | +78.7% |
| Q3 2021 | $1,339,000 | -66.6% | 8,400 | -72.4% | 0.09% | -71.0% |
| Q2 2021 | $4,003,000 | -72.5% | 30,425 | -73.0% | 0.32% | -33.7% |
| Q1 2021 | $14,535,000 | -36.8% | 112,790 | -18.1% | 0.49% | -51.7% |
| Q4 2020 | $22,982,000 | +2.7% | 137,790 | -5.0% | 1.01% | -37.4% |
| Q3 2020 | $22,376,000 | +4.3% | 145,000 | 0.0% | 1.62% | -5.2% |
| Q2 2020 | $21,446,000 | +470.2% | 145,000 | +107.1% | 1.71% | +503.2% |
| Q1 2020 | $3,761,000 | -61.0% | 70,000 | +0.9% | 0.28% | -81.9% |
| Q4 2019 | $9,655,000 | – | 69,400 | – | 1.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |